Razan Elkahlout

Razan Elkahlout

Auto-generated profile, based on publicly available information

Razan Elkahlout

Department of Research, Women's Wellness and Research Center Hamad Medical Corporation (HMC) Doha Qatar

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2025 in BMC Medical Genomics
Verified
Journal Article
Open access
Salma YounesSalma Younes
Salma Younes
RERazan Elkahlout
Razan Elkahlout
HKHouda Kilani
Houda Kilani
SOSarah Okashah
Sarah Okashah
HSHussain Al Sharshani
Hussain Al Sharshani
Nader Al-DewikNader Al-Dewik
Nader Al-Dewik
Background: Maple syrup urine disease (MSUD) is a hereditary metabolic disorder caused by a deficiency in the branched-chain α-keto acid dehydrogenase (BCKD) enzymatic complex. The Middle East and North Africa, and Türkiye (MENAT) region has witnessed a significant rise in the prevalence of MSUD due to high rates of consanguinity. Despite numerous genetic association studies, the complex relationships between genotype and phenotype in MSUD remain elusive. Aim: This study aimed to systematically review the variants significantly associated with MSUD in the MENAT region. Methods: We systematically searched four literature databases (PubMed, Scopus, Web of Science, and Science Direct) from inception until December 2023 to gather all reported genetic data pertaining to MSUD in the MENAT region. Quality assessment and data extraction were diligently performed by a team of six investigators. Results: A total of 16 studies, involving patients, were included in this systematic review. Among them, 211 patients presented with 105 variants located within genes known to be associated with MSUD. The majority of the identified MSUD variants were found in BCKDHA (38%), followed by BCKDHB (38%), DBT (23%), and PPM1K (1%). Notably, 77% of the captured variants were unique to the MENAT region. Conclusion: Our systematic review reveals a distinctive genetic and clinical susceptibility profile of MSUD among individuals from the MENAT region. These findings highlight the importance of understanding the specific genetic landscape of MSUD in this population. Further research is warranted to elucidate the complex genotype-phenotype relationships in MSUD in the MENAT region.

24 March 2025 in Proteomics – Clinical Applications
Verified
Journal Article
Open access
RERazan Elkahlout
Razan Elkahlout
SMSawsan G.A.A. Mohammed
Sawsan G.A.A. Mohammed
ANAhmed Najjar
Ahmed Najjar
TFThomas Farrell
Thomas Farrell
HRHilal Al Rifai
Hilal Al Rifai
M. WALID QORONFLEHM. WALID QORONFLEH
M. WALID QORONFLEH
Maternal and neonatal health (women during pregnancy, childbirth, and the postnatal period) presents a spectrum of healthcare challenges, including preterm birth, preeclampsia, intrauterine growth restriction, polycystic ovarian syndrome, and gestational diabetes mellitus. While genomic investigations have shed light on many of these topics, protein biomarker discovery, a pivotal aspect of such research, holds promise in offering insights into disease diagnosis, progression, and prognosis. This review paper aims to explore the landscape of proteomics research pertaining to the aforementioned disorders. In the search for viable biomarkers, existing ones are either outdated or lack specificity and new ones being investigated do not commonly make it to the validation stage. In this review, the reasons for the gap between the biomarker discovery stage and the clinical validation stage are evaluated, in addition to what steps are being taken to mitigate the unexpectedly slow scientific and clinical progress. Notably, this paper also delves into the ethnic disparities found in maternal and neonatal health research, as well as how AI is currently being used to alleviate socioeconomic and ethnic disparities, as well as its advantages for the analysis of large “omics” datasets. We anticipate this investigation will provide critical, invaluable information for researchers, medical professionals, and policy decision‐makers in this field to improve overall maternal and neonatal health outcomes.